Nano X Imaging Sees Q3 Sales $4.300M-$4.400M vs $5.453M Est
Nano X Imaging (NASDAQ:NNOX) sees Q3 sales of $4.300 million-$4.400 million vs $5.453 million analyst estimate.
Stocks · News reference
Nano X Imaging Q2 Adj. EPS $(0.17) Misses $(0.16) Estimate, Sales $4.156M Miss $5.385M Estimate
Nano X Imaging (NASDAQ:NNOX) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.16) by 6.25 percent. This is unchanged from the same period last year. The company reported
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nanox Reports Preliminary Q3 Revenue Of ~$4.3M-$4.4M, Up From $3.4M; Says ~$26M Cash And Deposits Not Sufficient For One Year, Raising Substantial Doubt About Going Concern
Nanox Announces Distribution Agreement With Tecnologie Avanzate Affiliate Technologic To Commercialize Nanox.AI Bone Solution In Italy
Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy
Nanox AI Ltd. has entered into a distribution agreement with Technologic s.r.l., an affiliate of Tecnologie Avanzate, to commercialize its HealthOST bone solution in Italy. The collaboration leverages Tecnologie Avanzate's 50 years of experience in the Italian medical technology market to expand Nanox.AI's commercial presence and bring AI-powered bone health assessment capabilities to Italian healthcare providers.